1-(3,5-Dimethylpyridin-2-yl)piperazine → 1-{5-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-6-methylpyridin-2-yl}-3,5-dimethylimidazolidine-2,4-dione
Reaction equation
[CH3:1][N:2]1[C:6](=[O:7])[CH:5]([CH3:8])[N:4]([C:9]2[CH:18]=[CH:17][C:12]([C:13]([O:15]C)=O)=[C:11]([CH3:19])[N:10]=2)[C:3]1=[O:20].[CH3:21][C:22]1[C:23]([N:29]2[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]2)=[N:24][CH:25]=[C:26]([CH3:28])[CH:27]=1>>[CH3:21][C:22]1[C:23]([N:29]2[CH2:30][CH2:31][N:32]([C:13]([C:12]3[CH:17]=[CH:18][C:9]([N:4]4[CH:5]([CH3:8])[C:6](=[O:7])[N:2]([CH3:1])[C:3]4=[O:20])=[N:10][C:11]=3[CH3:19])=[O:15])[CH2:33][CH2:34]2)=[N:24][CH:25]=[C:26]([CH3:28])[CH:27]=1Participants
3
Procedure
Using methyl 6-(3,5-dimethyl-2,4-dioxoimidazolidin-1-yl)-2-methylnicotinate (19 mg) described in Preparation Example 255 and 1-(3,5-dimethylpyridin-2-yl)piperazine (13 mg) described in Preparation Example 79 and by the reaction and treatment in the same manner as in Example 109, the title compound (24 mg) was obtained.
Workup
- customdescribed in Preparation Example 79 and by the reaction and treatment in the same manner as in Example 109
Sources & evidence
- ORD record
- ord-2686099e2e034cbdb8e755b9223751ba
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…